CoChat

Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscape

Open access
Kinoshita, Shotaro, Cortright, Kelley, Crawford, Allison, Mizuno, Yuya, Yoshida, Kazunari, Hilty, Donald, Guinart, Daniel, Torous, John, Correll, Christoph U., Castle, David J., Rocha, Deyvis, Yang, Yuan, Xiang, Yu-tao, Kølbæk, Pernille, Dines, David, ElShami, Mohammad, Jain, Prakhar, Kallivayalil, Roy, Solmi, Marco, Favaro, Angela, Veronese, Nicola, Seedat, Soraya, Shin, Sangho, Salazar de Pablo, Gonzalo, Chang, Chun-Hung, Su, Kuan-Pin, Karas, Hakan, Kane, John M., Yellowlees, Peter, Kishimoto, Taishiro · 2022 · Psychological Medicine
Cited by 114

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Background: During the COVID-19 pandemic, the use of telemedicine as a way to reduce COVID-19 infections was noted and consequently deregulated. However, the degree of telemedicine regulation varies from country to country, which may alter the widespread use of telemedicine. This study aimed to clarify the telepsychiatry regulations for each collaborating country/region before and during the COVID-19 pandemic. Methods: We used snowball sampling within a global network of international telepsychiatry experts. Thirty collaborators from 17 different countries/regions responded to a questionnaire on barriers to the use and implementation of telepsychiatric care, including policy factors such as regulations and reimbursement at the end of 2019 and as of May 2020. Results: Thirteen of 17 regions reported a relaxation of regulations due to the pandemic; consequently, all regions surveyed stated that telepsychiatry was now possible within their public healthcare systems. In some regions, restrictions on prescription medications allowed via telepsychiatry were eased, but in 11 of the 17 regions, there were still restrictions on prescribing medications via telepsychiatry. Lower insurance reimbursement amounts for telepsychiatry consultations v. in-person consultations were reevaluated in four regions, and consequently, in 15 regions telepsychiatry services were reimbursed at the same rate (or higher) than in-person consultations during the COVID-19 pandemic. Conclusions: Our results confirm that, due to COVID-19, the majority of countries surveyed are altering telemedicine regulations that had previously restricted the spread of telemedicine. These findings provide information that could guide future policy and regulatory decisions, which facilitate greater scale and spread of telepsychiatry globally.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0033291720004584

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 12

  1. 10.1001/jama.2020.7943 · DOI · Paper page
  2. 10.1377/hlthaff.2016.1461 · DOI · Paper page
  3. 10.1111/jpm.12251 · DOI
  4. 10.1016/j.amjmed.2013.09.032 · DOI · Paper page
  5. 10.1176/appi.ps.202000230 · DOI · Paper page
  6. 10.2196/18810 · DOI · Paper page
  7. 10.1016/j.genhosppsych.2019.11.004 · DOI · Paper page
  8. 10.1177/1932296820930033 · doi:10.1177/1932296820930033
  9. 10.1017/S109285290002277X · DOI · Paper page
  10. 10.1007/s41347-017-0016-4 · DOI
  11. 10.1089/tmj.2014.0116 · DOI
  12. 10.1176/appi.ps.201800286 · DOI · Paper page

Cited by

Metadata

Authors
Kinoshita, S., Cortright, K., Crawford, A., Mizuno, Y., Yoshida, K., Hilty, D., Guinart, D., Torous, J., Correll, C. U., Castle, D. J., Rocha, D., Yang, Y., Xiang, Y.-T., Kølbæk, P., Dines, D., ElShami, M., Jain, P., Kallivayalil, R., Solmi, M., Favaro, A., Veronese, N., Seedat, S., Shin, S., Salazar de Pablo, G., Chang, C.-H., Su, K.-P., Karas, H., Kane, J. M., Yellowlees, P., & Kishimoto, T.
Venue
Psychological Medicine
Published
2020-11-27
Volume
52
Issue
13
Pages
2606-2613
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W3106960351
Cited by
114
References
14
FWCI
12.56
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.